{"id":203377,"name":"CVS HEALTH","slug":"cvs-health","state":"DC","country":"United States of America","description":"&#226;€‹Pharmacy innovation and healthcare","totalSpending":1255000,"filings":32,"yearlySpending":[{"year":2019,"income":150000},{"year":2020,"income":205000},{"year":2021,"income":300000},{"year":2022,"income":240000},{"year":2023,"income":145000},{"year":2024,"income":105000},{"year":2025,"income":110000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"PHA","display":"Pharmacy"}],"firms":["KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)"],"lobbyists":["MAURA KEEFE","DANA SINGISER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Lowering the cost of health care and prescription drug prices, quality health care, patient outcomes, health care delivery, smoking cessation, and women's heart health.","Lowering the cost of health care and prescription drug prices, quality health care, patient outcomes, health care delivery, smoking cessation, and women's heart health.","Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care. Issues related to the proposed CVS-Aetna merg","Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health.","Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health."]}